These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results Terminated 2004-004835-72 A study to determine the effects of growth hormone (GH) replacement therapy on quality of life and cardiovascualr risk in GH deficient adults 2013-10-23 due-trials
Other 2004-005034-39 Nicotinamide,vitamin B3, metabolic pathways in patients with early idiopathic parkinson's disease not-yet-due
Other 2005-000755-15 Perhexiline therapy in patients with Hypertrophic Cardiomyopathy not-yet-due
Not reported 2005-004021-26 Longitudinal relationship between lipodystrophy and adipocyte mitochondria DNA in HIV Patients: comparison between Efavirenz (Sustiva) plus AZT/3TC (Combivir) and a less mitochrondial DNA-toxic regime... 2011-05-31 due-trials
Not reported 2005-005898-29 The effect of bosentan, a selective endothelin antagonist, on cardiovascular performance in patients with a Fontan circulation 2010-12-01 due-trials
Other 2006-000436-27 Neoadjuvant trial of pre-operative exemestane or letrozole +/-celecoxib in the treatment of ER positive postmenopausal early breast cancer. not-yet-due
Not reported 2006-001428-38 Remission Induction in Very Early Rheumatoid Arthritis (RIVERA): a comparison of etanercept plus methotrexate plus steroid with standard therapy 2010-05-30 due-trials
Other 2006-002638-39 Mechanisms responsible for cardiac and skeletal muscle energetic impairment in type 1 diabetes not-yet-due
Not reported 2006-003164-62 Metabolic Support with Perhexilene to Protect Myocardium undergoing Coronary Artery Surgery 2010-04-30 due-trials
Not reported Terminated 2006-003426-28 Cortisol metabolism and impaired glucose tolerance 2011-02-08 due-trials
Reported results 2006-006275-21 A Randomised, Pragmatic, Open-label study of Adalimumab versus Etanercept for Rheumatoid Arthritis. 2011-07-05 due-trials
Not reported Terminated 2007-002914-20 Calcineurin Inhibitor Minimisation in Renal Transplant Recipients with Stable Allograft Function: A Prospective Randomised Controlled Trial 2009-05-29 due-trials
Not reported 2007-003968-22 European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy 2015-09-30 due-trials
Reported results 2007-004869-18 Evaluation of the relative severity of pulmonary neutrophilic inflammation and therapeutic modification with IV Prolastin by means of 18 FDG PET/CT scanning in subjects with alpha1-antitrypsin deficie... 2010-09-30 due-trials
Not reported Terminated 2008-002376-95 Myocardial protection with Perhexiline in Left Ventricular Hypertrophy 2012-08-30 due-trials
Not reported 2008-003727-23 Does phosphate binding with sevelamer carbonate improve cardiovascular structure and function in patients with early chronic kidney disease? 2010-10-28 due-trials
Other 2008-006295-29 A single group trial evaluating one cycle of adjuvant BEP chemotherapy in high risk, stage 1 non-seminomatous germ cell tumours of the testis (NSGCTT) not-yet-due
Reported results 2009-012033-30 Phase II Study of the Adjunctive Use of Lenalidomide in Patients Undergoing Reduced Intensity Conditioning Allogeneic Transplantation for Multiple Myeloma 2018-12-19 due-trials
Not reported 2009-015077-12 The use of corticosteroids (Budenofalk) as a chemopreventative agent in ulcerative colitis associated neoplasia 2014-09-30 due-trials
Not reported Terminated 2009-016003-26 RANDOMISED PILOT TRIAL OF MYFORTIC FOR THE TREATMENT OF PRIMARY PROTEINURIC GLOMERULONEPHRITIS. 2012-10-02 due-trials
Not reported 2009-016909-42 Effect of topical imiquimod on lentigo maligna. 2012-03-19 due-trials
Not reported 2010-019296-30 A pharmacokinetic and pharmacodynamic study of recombinant human IGF-I (rhIGF-I) in three boys with ALS deficiency, and insulin sensitivity and bone density in patients and heterozygous first-degree r... 2012-01-01 due-trials
Reported results 2010-024646-30 Anti-viral prophylaxis for prevention of cytomegalovirus (CMV) reactivation in immunocompetent patients in critical care. 2017-01-19 due-trials
Reported results 2012-002552-16 Cabazitaxel in platinum pre-treated patients with locally advanced or metastatic transitional cell carcinoma who developed disease progression within 12 months of platinum based chemotherapy. 2017-12-31 due-trials
Not reported 2012-003756-36 The Use of Glyceryl Trinitrate Patches in Arteriovenous Fistulas 2015-07-01 due-trials
Reported results Terminated 2013-003867-76 A prospective, randomised controlled trial to determine the safety and efficacy of steroid impregnated tape compared to standard therapy with silver nitrate in the treatment of over-granulating perito... 2017-03-01 due-trials
Reported results 2014-001823-56 A randomised controlled trial to compare the clinical effectiveness and safety of gentamicin and ceftriaxone in the treatment of gonorrhoea. 2017-01-20 due-trials
Other 2015-001401-13 A Multi-Centre Randomised Controlled Trial of Pre-Hospital Blood Product Administration versus Standard Care for Traumatic Haemorrhage not-yet-due
Other 2016-004250-15 A prospective, phase II, single centre, cross-sectional, randomised trial investigating Dehydroepiandrosterone and it's Pharmacokinetics in Trauma not-yet-due
Reported results 2016-004483-19 A randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis 2020-02-26 due-trials
Other 2017-001785-14 STRESS-L: STudy into the REversal of Septic Shock with Landiolol (Beta Blockade) not-yet-due
Other 2017-003481-28 A pilot randomised controlled trial to examine the efficacy and optimal dose of Acetic Acid to treat colonised burns wounds. not-yet-due
Other 2018-003254-24 AGe-adapted benefits of Envarsus versus twice-daily tacrolimus ImmunosuppressioN druGs after kidney transplantation (AGEING) – a feasibility study not-yet-due
Other 2019-001688-66 Sugar or Salt (SOS) trial: Hyperosmolar therapy in traumatic brain injury not-yet-due